A detailed history of Assenagon Asset Management S.A. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 293,083 shares of ARWR stock, worth $5.86 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
293,083
Previous 88,150 232.48%
Holding current value
$5.86 Million
Previous $2.29 Million 147.66%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$19.36 - $29.54 $3.97 Million - $6.05 Million
204,933 Added 232.48%
293,083 $5.67 Million
Q2 2024

Jul 18, 2024

SELL
$21.87 - $28.24 $5.61 Million - $7.24 Million
-256,317 Reduced 74.41%
88,150 $2.29 Million
Q1 2024

Apr 24, 2024

BUY
$27.21 - $39.48 $8.33 Million - $12.1 Million
306,059 Added 796.86%
344,467 $9.85 Million
Q4 2023

Jan 17, 2024

SELL
$21.2 - $31.03 $8.1 Million - $11.9 Million
-381,964 Reduced 90.86%
38,408 $1.18 Million
Q3 2023

Nov 06, 2023

SELL
$26.2 - $36.08 $2.03 Million - $2.79 Million
-77,386 Reduced 15.55%
420,372 $11.3 Million
Q2 2023

Jul 25, 2023

BUY
$25.16 - $41.38 $1.87 Million - $3.08 Million
74,451 Added 17.59%
497,758 $17.8 Million
Q1 2023

Apr 18, 2023

BUY
$23.68 - $38.51 $10 Million - $16.3 Million
423,307 New
423,307 $10.8 Million
Q2 2022

Jul 27, 2022

SELL
$27.79 - $50.61 $3.2 Million - $5.82 Million
-115,082 Reduced 88.73%
14,619 $515,000
Q1 2022

Apr 25, 2022

BUY
$39.62 - $69.97 $4.81 Million - $8.49 Million
121,336 Added 1450.52%
129,701 $5.97 Million
Q4 2021

Feb 01, 2022

SELL
$58.09 - $82.51 $217,488 - $308,917
-3,744 Reduced 30.92%
8,365 $555,000
Q3 2021

Oct 19, 2021

BUY
$58.38 - $84.96 $706,923 - $1.03 Million
12,109 New
12,109 $756,000
Q1 2020

Apr 17, 2020

SELL
$20.56 - $63.12 $117,315 - $360,162
-5,706 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$28.14 - $73.01 $160,566 - $416,595
5,706 New
5,706 $362,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.11B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.